M. ÇELİK Et Al. , "Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey," Journal of Neurology , vol.271, no.7, pp.4131-4137, 2024
ÇELİK, M. Et Al. 2024. Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey. Journal of Neurology , vol.271, no.7 , 4131-4137.
ÇELİK, M., Baba, C., IRMAK, Ç., Özakbaş, S., & AVKAN OĞUZ, V., (2024). Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey. Journal of Neurology , vol.271, no.7, 4131-4137.
ÇELİK, MUAMMER Et Al. "Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey," Journal of Neurology , vol.271, no.7, 4131-4137, 2024
ÇELİK, MUAMMER Et Al. "Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey." Journal of Neurology , vol.271, no.7, pp.4131-4137, 2024
ÇELİK, M. Et Al. (2024) . "Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey." Journal of Neurology , vol.271, no.7, pp.4131-4137.
@article{article, author={MUAMMER ÇELİK Et Al. }, title={Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey}, journal={Journal of Neurology}, year=2024, pages={4131-4137} }